To print this article, all you need is to be registered or login on Mondaq.com.
First published as part of Miriam Zanker, Suzy Roessel,
Elizabeth Godfrey and Linda Xu, Current Developments -
Australia: Comprising : A double-edged sword -
Merck
Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA
1477 (14 October 2020) and Not so sweet victory for wicked
business:
PDP Capital Pty Ltd v Grasshopper Ventures Pty
LTd [2020] FCA 1078 (30 July 2020) (2020) 122
Intellectual Property Forum 91.
In the recent Federal Court of Australia decision in
Merck
Sharp & Dohme Corporation v Wyeth LLC (No 3) [2020] FCA
1477, Justice Burley held that the proposed importation and sale of
To print this article, all you need is to be registered or login on Mondaq.com.
This article was written by ipervescence in collaboration
with Davies Collison Cave. ipervescence is a joint venture between
its Managing Principals and QANTM Intellectual Property Limited
Intellectual property is embedded throughout a business. It
underpins and connects critical capabilities including how a
business operates, manages people, innovates and collaborates. The
real value of IP lies in its broad based contribution, and how
effectively that contribution supports business objectives.
This article considers how an integrated approach to IP supports
the way a business generates value and mitigates risk.
SHANGHAI (Reuters) - Shares in Apple Inc supplier Luxshare Precision Industry Co Ltd fell as much as 9.5% on Monday, amid fresh concerns about a patent infringement investigation filed against it from the United States. On Sunday, in a stock market filing, the company said it had been informed of two notices issued by the United States International Trade Commission (USITC) regarding a Section 337 investigation filed against it by U.S.-based Amphenol Corp, alleging IP infringement. Luxshare said it had hired a team of lawyers to respond and would follow procedure on the investigation, without elaborating, but re-iterated that the case will not have a material impact on its current operations and production.
By Reuters Staff
2 Min Read
SHANGHAI (Reuters) - Shares in Apple Inc supplier Luxshare Precision Industry Co Ltd fell as much as 9.5% on Monday, amid fresh concerns about a patent infringement investigation filed against it from the United States.
On Sunday, in a stock market filing, the company said it had been informed of two notices issued by the United States International Trade Commission (USITC) regarding a Section 337 investigation filed against it by U.S.-based Amphenol Corp, alleging IP infringement.
Luxshare said it had hired a team of lawyers to respond and would “follow procedure” on the investigation, without elaborating, but re-iterated that the case “will not have a material impact” on its current operations and production.
CSPs).
(a) COVID-19
In response to the COVID-19 pandemic, the federal government
pursued Interim Orders and other policy changes intended to
expedite the development of COVID-19-related products, including
drugs, vaccines, hand sanitizers, disinfectants, personal
protective equipment, and medical devices (see
e.g., here and here). Both the federal and provincial
governments made regulatory changes to secure domestic drug
supplies and mitigate shortages (see
e.g., here and here). Many of these policies were passed on
an interim basis but still remain in effect.
Patent Act, adding a
provision that allowed the Minister of Health to apply for
authorization to make, construct, use, and sell a patented